|
|
|
|
|
|
Kura Oncology (KURA)
|
|
14.10 +0.50 (+3.68%)
|
10/16/2017 4:00pm
|
|
Open:
|
13.80
|
Pre. Close:
|
13.60
|
|
High:
|
14.20
|
Low:
|
13.80
|
|
Volume:
|
506,040
|
Market Cap:
|
281.83M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.98 - 14.9
|
14.9 - 14.47
|
|
Low:
|
13.13 - 13.22
|
13.22 - 13.67
|
|
Close:
|
13.61 - 13.73
|
13.73 - 14.36
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-16 4:45:26 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 17.87 One year: 20.87
|
|
Support:
|
Support1: 12.55 Support2: 10.85
|
|
Resistance:
|
Resistance1:
15.30 Resistance2: 17.87
|
|
Pivot:
|
14.03
|
|
Moving Averages:
|
MA(5): 14.01 MA(20): 13.64
MA(100): 9.62 MA(250): 8.18
|
|
MACD:
|
MACD(12,26):
0.94  Signal(12,26,9): 1.15
|
|
%K %D:
|
%K(14,3): 56.44 %D(3): 62.00
|
|
RSI:
|
RSI(14): 62.34
|
|
52-Week:
|
High: 15.30
Low: 4.00 Change(%): 163.6
|
|
Average Vol(K):
|
3-Month: 79319
10-Days 16356
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.KURA has closed below upper band by 46.2%. Bollinger Bands are 42% narrower than normal. The narrow width of the bands suggests low volatility as compared to KURA's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Mon, 02 Oct 2017 11:03:45 GMT
Short Interest in Kura Oncology, Inc. (KURA) Rises By 58.9%
Mon, 16 Oct 2017 11:26:15 GMT
Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS ...
Fri, 08 Sep 2017 13:38:40 GMT
Kura Oncology Inc. (KURA) Is Up Sharply On Phase 2 Study Results
Tue, 03 Jan 2017 21:00:00 GMT
Kura Oncology Appoints Steven Stein, MD to Board of Directors
Fri, 08 Sep 2017 11:48:45 GMT
Kura Oncology's stock rockets after positive results from cancer treatment trial
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
